451 related articles for article (PubMed ID: 18315446)
1. Serotonin transporter polymorphism (5-HTTLPR) and citalopram effectiveness and side effects in children with depression and/or anxiety disorders.
Kronenberg S; Apter A; Brent D; Schirman S; Melhem N; Pick N; Gothelf D; Carmel M; Frisch A; Weizman A
J Child Adolesc Psychopharmacol; 2007 Dec; 17(6):741-50. PubMed ID: 18315446
[TBL] [Abstract][Full Text] [Related]
2. Serotonin transporter polymorphism as a predictor for escitalopram treatment of major depressive disorder comorbid with alcohol dependence.
Muhonen LH; Lahti J; Alho H; Lönnqvist J; Haukka J; Saarikoski ST
Psychiatry Res; 2011 Mar; 186(1):53-7. PubMed ID: 20800901
[TBL] [Abstract][Full Text] [Related]
3. Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression.
Hu XZ; Rush AJ; Charney D; Wilson AF; Sorant AJ; Papanicolaou GJ; Fava M; Trivedi MH; Wisniewski SR; Laje G; Paddock S; McMahon FJ; Manji H; Lipsky RH
Arch Gen Psychiatry; 2007 Jul; 64(7):783-92. PubMed ID: 17606812
[TBL] [Abstract][Full Text] [Related]
4. Additive effects of 5-HTTLPR (serotonin transporter) and tryptophan hydroxylase 2 G-703T gene polymorphisms on the clinical response to citalopram among children and adolescents with depression and anxiety disorders.
Rotberg B; Kronenberg S; Carmel M; Frisch A; Brent D; Zalsman G; Apter A; Weizman A
J Child Adolesc Psychopharmacol; 2013 Mar; 23(2):117-22. PubMed ID: 23510446
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetics of citalopram-related side effects in children with depression and/or anxiety disorders.
Amitai M; Kronenberg S; Carmel M; Michaelovsky E; Frisch A; Brent D; Apter A; Chen A; Weizman A; Fennig S
J Neural Transm (Vienna); 2016 Nov; 123(11):1347-1354. PubMed ID: 27324805
[TBL] [Abstract][Full Text] [Related]
6. Serotonin transporter promoter region polymorphisms do not influence treatment response to escitalopram in patients with major depression.
Maron E; Tammiste A; Kallassalu K; Eller T; Vasar V; Nutt DJ; Metspalu A
Eur Neuropsychopharmacol; 2009 Jun; 19(6):451-6. PubMed ID: 19272758
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness and safety of citalopram in hospitalized adolescents with major depression: a preliminary, 8-week, fixed-dose, open-label, prospective study.
Shoval G; Nahshoni E; Gothelf D; Manor I; Golobchik P; Zemishlany Z; Weizman A; Zalsman G
Clin Neuropharmacol; 2011; 34(5):182-5. PubMed ID: 21926484
[TBL] [Abstract][Full Text] [Related]
8. Association between serotonin transporter-linked polymorphic region and escitalopram antidepressant treatment response in Korean patients with major depressive disorder.
Won ES; Chang HS; Lee HY; Ham BJ; Lee MS
Neuropsychobiology; 2012; 66(4):221-9. PubMed ID: 23095326
[TBL] [Abstract][Full Text] [Related]
9. Association of a triallelic serotonin transporter gene promoter region (5-HTTLPR) polymorphism with stressful life events and severity of depression.
Zalsman G; Huang YY; Oquendo MA; Burke AK; Hu XZ; Brent DA; Ellis SP; Goldman D; Mann JJ
Am J Psychiatry; 2006 Sep; 163(9):1588-93. PubMed ID: 16946185
[TBL] [Abstract][Full Text] [Related]
10. Citalopram and suicidality in adult major depression and anxiety disorders.
Pedersen AG
Nord J Psychiatry; 2006; 60(5):392-9. PubMed ID: 17038305
[TBL] [Abstract][Full Text] [Related]
11. Association of serotonin transporter promoter gene polymorphism (5-HTTLPR) with depression in Costa Rican schizophrenic patients.
Contreras J; Hernández S; Quezada P; Dassori A; Walss-Bass C; Escamilla M; Raventos H
J Neurogenet; 2010 Jul; 24(2):83-9. PubMed ID: 20397838
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness and tolerability of citalopram for the treatment of depression and anxiety disorders in children and adolescents: an open-label study.
Schirman S; Kronenberg S; Apter A; Brent D; Melhem N; Pick N; Carmel M; Frisch A; Weizman A; Gothelf D
J Neural Transm (Vienna); 2010 Jan; 117(1):139-45. PubMed ID: 19851705
[TBL] [Abstract][Full Text] [Related]
13. Serotonin transporter promoter region (5-HTTLPR) polymorphism is associated with the intravaginal ejaculation latency time in Dutch men with lifelong premature ejaculation.
Janssen PK; Bakker SC; Réthelyi J; Zwinderman AH; Touw DJ; Olivier B; Waldinger MD
J Sex Med; 2009 Jan; 6(1):276-84. PubMed ID: 19170855
[TBL] [Abstract][Full Text] [Related]
14. Serotonin transporter gene (SLC6A4) polymorphisms are associated with response to fluoxetine in south Indian major depressive disorder patients.
Manoharan A; Shewade DG; Rajkumar RP; Adithan S
Eur J Clin Pharmacol; 2016 Oct; 72(10):1215-1220. PubMed ID: 27439447
[TBL] [Abstract][Full Text] [Related]
15. 5-HTTLPR polymorphism of the serotonin transporter gene predicts non-remission in major depression patients treated with citalopram in a 12-weeks follow up study.
Arias B; Catalán R; Gastó C; Gutiérrez B; Fañanás L
J Clin Psychopharmacol; 2003 Dec; 23(6):563-7. PubMed ID: 14624186
[TBL] [Abstract][Full Text] [Related]
16. Effect of the 5-HTTLPR polymorphism in the serotonin transporter gene on major depressive disorder and related comorbid disorders.
Verhagen M; van der Meij A; Janzing JG; Arias-Vásquez A; Buitelaar JK; Franke B
Psychiatr Genet; 2009 Feb; 19(1):39-44. PubMed ID: 19125107
[TBL] [Abstract][Full Text] [Related]
17. [Relationship between serotonin transporter gene 5HTTLPR polymorphism and the symptoms of neuroticism in a healthy population].
Gonda X; Bagdy G
Psychiatr Hung; 2006; 21(5):379-85. PubMed ID: 17297200
[TBL] [Abstract][Full Text] [Related]
18. A double-blind, placebo-controlled treatment trial of citalopram for major depressive disorder in older patients with heart failure: the relevance of the placebo effect and psychological symptoms.
Fraguas R; da Silva Telles RM; Alves TC; Andrei AM; Rays J; Iosifescu DV; Wajngarten M
Contemp Clin Trials; 2009 May; 30(3):205-11. PubMed ID: 19470312
[TBL] [Abstract][Full Text] [Related]
19. 5-HTTLPR Genotype-Specific Phenotype in Children and Adolescents With Autism.
Brune CW; Kim SJ; Salt J; Leventhal BL; Lord C; Cook EH
Am J Psychiatry; 2006 Dec; 163(12):2148-56. PubMed ID: 17151167
[TBL] [Abstract][Full Text] [Related]
20. Quetiapine as combination treatment with citalopram in unipolar depression with prominent somatic symptoms: a randomised, double-blind, placebo-controlled pilot study.
Quante A; Regen F; Schindler F; Volkmer K; Severus E; Urbanek C; Luborzewski A; Roepke S; Anghelescu I
Psychiatr Danub; 2013 Sep; 25(3):214-20. PubMed ID: 24048387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
